tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ritu Baral, 17 are a HOLD (8.95%), 172 are a BUY (90.53%), 1 are a SELL (0.53%).
Analyst Ritu Baral, currently employed at TD COWEN, carries an average stock price target met ratio of 54.31% that have a potential upside of 38.97% achieved within 445 days.
Ritu Baral’s has documented 363 price targets and ratings displayed on 39 stocks. The coverage is on Healthcare, Industrials, Basic Materials sectors.
Most recent stock forecast was given on VERA, Vera Therapeutics at 08-Jul-2026.
Analyst best performing recommendations are on SAGE (SAGE THERAPEUTIC).
The best stock recommendation documented was for SAGE (SAGE THERAPEUTIC) at 7/30/2024. The price target of $10 was fulfilled within 2 days with a profit of $0.8 (7.41%) receiving and performance score of 37.04.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 07-Mar-2025
$28
$0.71 (2.60%)
29 days ago
(25-Aug-2026)
24/30 (80%)
$-2.57 (-8.41%)
206
Buy Since 21-Oct-2025
$40
$12.71 (46.57%)
$39
29 days ago
(25-Aug-2026)
0/6 (0%)
$9.43 (30.85%)
Buy Since 25-Sep-2025
$38
$10.71 (39.25%)
$29
29 days ago
(25-Aug-2026)
2/5 (40%)
$7.43 (24.30%)
574
Buy Since 17-Oct-2023
$49
$21.71 (79.55%)
$40
1 months 6 days ago
(17-Aug-2026)
2/10 (20%)
$19.99 (68.91%)
467
Buy Since 28-Feb-2024
$41
$13.71 (50.24%)
$29
1 months 11 days ago
(12-Aug-2026)
9/12 (75%)
$11.55 (39.22%)
393
Which stock is Ritu Baral most bullish on?
Which stock is Ritu Baral most reserved on?
What Year was the first public recommendation made by Ritu Baral?
